LeeH, SowerbyLJ, TempleCL, YuE, MooreCC. Carbon dioxide laser treatment for lentigo maligna: a retrospective review comparing 3 different treatment modalities.. Arch Facial Plast Surg. 2011; 13(6):398–403
2.
MadanV, AugustPJ. Lentigo maligna: outcomes of treatment with Q-switched Nd:YAG and alexandrite lasers.. Dermatol Surg. 2009; 35(4):607–612 19309345
3.
LeePK, RosenbergCN, TsaoH, SoberAJ. Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases.. J Am Acad Dermatol. 1998; 38(2, pt 2):314–317 9486705
4.
McLeodM, ChoudharyS, GiannakakisG, NouriK. Surgical treatments for lentigo maligna: a review.. Dermatol Surg. 2011; 21631635
5.
MamoonAM, Gamal-EldeenAM, RuppelME, SmithRJ, TsangT, MillerLM. In vitro efficiency and mechanistic role of indocyanine green as photodynamic therapy agent for human melanoma.. Photodiagnosis Photodyn Ther. 2009; 6(2):105–116 19683211
6.
TannousZS, LernerLH, DuncanLM, MihmMCJr, FlotteTJ. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.. Hum Pathol. 2000; 31(6):705–708 10872664
7.
TannousZS, MihmMC, FlotteTJ, GonzálezS. In vivo examination of lentigo maligna and malignant melanoma in situ, lentigo maligna type by near-infrared reflectance confocal microscopy: comparison of in vivo confocal images with histologic sections.. J Am Acad Dermatol. 2002; 46(2):260–263 11807439
8.
WeinstockMA, SoberAJ. The risk of progression of lentigo maligna to lentigo maligna melanoma.. Br J Dermatol. 1987; 116(3):303–310 3567069
9.
DavisJ, PackGT, HigginsGK. Melanotic freckle of Hutchinson.. Am J Surg. 1967; 113(4):457–463 6023013
